Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 53 articles: HTML format Text format

Single Articles

March 2010
1. GAGNON B , Abrahamowicz M, Xiao Y, Beauchamp ME, et al
   Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. KREMER R , Best LA, Savulescu D, Gavish M, et al
   Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. AMERI K , Luong R, Zhang H, Powell AA, et al
   Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.
   Br J Cancer. 2010;102:561-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. CASTLEBERRY AW , Grannis FW Jr
   What is a reasonable cost to refute a preposterous hypothesis?
   Br J Cancer. 2010;102:627-8.
   PubMed     Text format     Related articles   
   
   
   
5. KOHLER S , Ullrich S, Richter U, Schumacher U, et al
   E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung.
   Br J Cancer. 2010;102:602-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
6. PUGLISI M , Dolly S, Faria A, Myerson JS, et al
   Treatment options for small cell lung cancer - do we have more choice?
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
7. VROLING L , Lind JS, de Haas RR, Verheul HM, et al
   CD133(+) circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. KOH WP , Yuan JM, Wang R, Lee HP, et al
   Body mass index and smoking-related lung cancer risk in the Singapore Chinese Health Study.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
9. VAN DEN BERGH KA , Essink-Bot ML, Borsboom GJ, Th Scholten E, et al
   Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON).
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. KISHIDA Y , Kawahara M, Teramukai S, Kubota K, et al
    Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03.
    Br J Cancer. 2009;101:1537-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
11. NOVELLO S , Scagliotti GV, Rosell R, Socinski MA, et al
    Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
12. DUFFY SW
    Cost of a 5-year lung cancer survivor.
    Br J Cancer. 2009;101:881.
    PubMed     Text format     Related articles   
    
    
    
13. REICH JM
    Cost-effectiveness of computed tomography lung cancer screening.
    Br J Cancer. 2009;101:879-80.
    PubMed     Text format     Related articles   
    
    
    August 2009
14. CRAWFORD SM , Sauerzapf V, Haynes R, Zhao H, et al
    Social and geographical factors affecting access to treatment of lung cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. CASTLEBERRY AW , Smith D, Anderson C, Rotter AJ, et al
    Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. LESTUZZI C , Lafaras C, Bearz A, Gralec R, et al
    Malignant pericardial effusion: sclerotherapy or local chemotherapy?
    Br J Cancer. 2009;101:734-5.
    PubMed     Text format     Related articles   
    
    
    July 2009
17. OHYANAGI F , Yamamoto N, Horiike A, Harada H, et al
    Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Br J Cancer. 2009;101:225-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
18. MENG XN , Jin Y, Yu Y, Bai J, et al
    Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. JAVLE M , Yu J, Garrett C, Pande A, et al
    Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study.
    Br J Cancer. 2009;100:1842-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. FERRUCCI LM , Cross AJ, Graubard BI, Brinton LA, et al
    Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. CAMBIEN B , Karimdjee BF, Richard-Fiardo P, Bziouech H, et al
    Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
    Br J Cancer. 2009;100:1755-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
22. PFEIFFER M , Hartmann TN, Leick M, Catusse J, et al
    Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. FOREST V , Hadjeres R, Bertrand R, Jean-Francois R, et al
    Optimisation and molecular signalling of apoptosis in sequential cryotherapy and chemotherapy combination in human A549 lung cancer xenografts in SCID mice.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
24. KETTUNEN E , Aavikko M, Nymark P, Ruosaari S, et al
    DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. BEAU-FALLER M , Legrain M, Voegeli AC, Guerin E, et al
    Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping.
    Br J Cancer. 2009;100:985-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. TANAI C , Nokihara H, Yamamoto S, Kunitoh H, et al
    Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
27. AGARWAL S , Zerillo C, Kolmakova J, Christensen JG, et al
    Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. WAILOO A , Sutton A, Morgan A
    The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis.
    Br J Cancer. 2009;100:436-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
29. MAHONEY CL , Choudhury B, Davies H, Edkins S, et al
    LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition.
    Br J Cancer. 2009;100:370-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. KING M , Jones L, McCarthy O, Rogers M, et al
    Development and pilot evaluation of a complex intervention to improve experienced continuity of care in patients with cancer.
    Br J Cancer. 2009;100:274-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. KUNITOH H , Tamura T, Shibata T, Imai M, et al
    A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811).
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. PLOWRIGHT L , Harrington KJ, Pandha HS, Morgan R, et al
    HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer).
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. GALLEGES RUIZ MI , Floor K, Steinberg SM, Grunberg K, et al
    Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients.
    Br J Cancer. 2009;100:145-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. NEUHAUS T , Ko Y, Muller RP, Grabenbauer GG, et al
    A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
35. MCKEAGE MJ , Von Pawel J, Reck M, Jameson MB, et al
    Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer.
    Br J Cancer. 2008;99:2006-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. GRUNFELD E , Watters JM, Urquhart R, O'Rourke K, et al
    A prospective study of peri-diagnostic and surgical wait times for patients with presumptive colorectal, lung, or prostate cancer.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. HOSGOOD HD 3RD , Chapman R, Shen M, Blair A, et al
    Portable stove use is associated with lower lung cancer mortality risk in lifetime smoky coal users.
    Br J Cancer. 2008;99:1934-1939.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
38. KIKUCHI J , Kinoshita I, Shimizu Y, Oizumi S, et al
    Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. COUPLAND VH , Chapman P, Linklater KM, Sehgal A, et al
    Trends in the epidemiology of larynx and lung cancer in south-east England, 1985-2004.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. MAASER K , Borlak J
    A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators.
    Br J Cancer. 2008;99:1635-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. SEKINE I , Yamamoto N, Nishio K, Saijo N, et al
    Emerging ethnic differences in lung cancer therapy.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
42. AL-SAAD S , Al-Shibli K, Donnem T, Persson M, et al
    The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
43. ZEE YK , Eisen T
    Survival from lung cancer in England and Wales up to 2001.
    Br J Cancer. 2008;99 Suppl 1:S43-6.
    PubMed     Text format     Related articles   
    
    
    
44. RACHET B , Quinn MJ, Cooper N, Coleman MP, et al
    Survival from cancer of the lung in England and Wales up to 2001.
    Br J Cancer. 2008;99 Suppl 1:S40-2.
    PubMed     Text format     Related articles   
    
    
    
45. TANG Z , Du R, Jiang S, Wu C, et al
    Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.
    Br J Cancer. 2008;99:911-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. KALIKAKI A , Koutsopoulos A, Trypaki M, Souglakos J, et al
    Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.
    Br J Cancer. 2008;99:923-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. TEKLE C , Giovannetti E, Sigmond J, Graff JR, et al
    Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells.
    Br J Cancer. 2008;99:750-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. MAKOWSKI L , Hayes DN
    Role of LKB1 in lung cancer development.
    Br J Cancer. 2008;99:683-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. LI Q , Kakizaki M, Kuriyama S, Sone T, et al
    Green tea consumption and lung cancer risk: the Ohsaki study.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
50. TANG Z , Du R, Jiang S, Wu C, et al
    Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. KUNITOH H , Kato H, Tsuboi M, Asamura H, et al
    A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204).
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. BAKA S , Califano R, Ferraldeschi R, Aschroft L, et al
    Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer.
    Br J Cancer. 2008;99:442-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
53. FIELD JK , Duffy SW
    Lung cancer screening: the way forward.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: